36 related articles for article (PubMed ID: 18484647)
1. Human Lactoferrin Synergizes with Etoposide to Inhibit Lung Adenocarcinoma Cell Growth While Attenuating Etoposide-Mediated Cytotoxicity of Human Endothelial Cells.
Olszewska P; Pazdrak B; Kruzel ML
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289691
[TBL] [Abstract][Full Text] [Related]
2. Plasmalemmal V-ATPase as a Potential Biomarker for Lactoferrin-Based Anticancer Therapy.
Santos-Pereira C; Rodrigues LR; Côrte-Real M
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053267
[TBL] [Abstract][Full Text] [Related]
3. Kidney protective potential of lactoferrin: pharmacological insights and therapeutic advances.
Zahan MS; Ahmed KA; Moni A; Sinopoli A; Ha H; Uddin MJ
Korean J Physiol Pharmacol; 2022 Jan; 26(1):1-13. PubMed ID: 34965991
[TBL] [Abstract][Full Text] [Related]
4. A Novel Human Recombinant Lactoferrin Inhibits Lung Adenocarcinoma Cell Growth and Migration with No Cytotoxic Effect on Normal Human Epithelial Cells.
Olszewska P; Pazdrak B; Kruzel ML
Arch Immunol Ther Exp (Warsz); 2021 Nov; 69(1):33. PubMed ID: 34748082
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antitumor activity of bovine lactoferrin through immobilization onto functionalized nano graphene oxide: an
Najmafshar A; Rostami M; Varshosaz J; Norouzian D; Samsam Shariat SZA
Drug Deliv; 2020 Dec; 27(1):1236-1247. PubMed ID: 32812454
[TBL] [Abstract][Full Text] [Related]
6. Bovine Milk Lactoferrin Selectively Kills Highly Metastatic Prostate Cancer PC-3 and Osteosarcoma MG-63 Cells
Guedes JP; Pereira CS; Rodrigues LR; Côrte-Real M
Front Oncol; 2018; 8():200. PubMed ID: 29915723
[TBL] [Abstract][Full Text] [Related]
7. Effects of talactoferrin alpha on lung adenoma prevention in A/J mice June 2, 2016.
Seabloom DE; Galbraith AR; Haynes AM; Fujita AS; Antonides JD; Wuertz BR; Steele VE; Ondrey FG; Wattenberg LW
Am J Transl Res; 2018; 10(3):875-880. PubMed ID: 29636877
[TBL] [Abstract][Full Text] [Related]
8. Lactoferrin selectively triggers apoptosis in highly metastatic breast cancer cells through inhibition of plasmalemmal V-H+-ATPase.
Pereira CS; Guedes JP; Gonçalves M; Loureiro L; Castro L; Gerós H; Rodrigues LR; Côrte-Real M
Oncotarget; 2016 Sep; 7(38):62144-62158. PubMed ID: 27556694
[TBL] [Abstract][Full Text] [Related]
9. The effect of carbohydrate moiety structure on the immunoregulatory activity of lactoferrin in vitro.
Zimecki M; Artym J; Kocięba M; Duk M; Kruzel ML
Cell Mol Biol Lett; 2014 Jun; 19(2):284-96. PubMed ID: 24820230
[TBL] [Abstract][Full Text] [Related]
10. Bovine lactoferrin ameliorates ferric nitrilotriacetate-induced renal oxidative damage in rats.
Okazaki Y; Kono I; Kuriki T; Funahashi S; Fushimi S; Iqbal M; Okada S; Toyokuni S
J Clin Biochem Nutr; 2012 Sep; 51(2):84-90. PubMed ID: 22962523
[TBL] [Abstract][Full Text] [Related]
11. Talactoferrin immunotherapy in metastatic renal cell carcinoma: a case series of four long-term survivors.
Lewis MA; Hayes TG
J Clin Med Res; 2011 Feb; 3(1):47-51. PubMed ID: 22043271
[TBL] [Abstract][Full Text] [Related]
12. The role of talactoferrin alpha in the treatment of non-small cell lung cancer.
Kelly RJ; Giaccone G
Expert Opin Biol Ther; 2010 Sep; 10(9):1379-86. PubMed ID: 20684737
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin conjugated with 40-kDa branched poly(ethylene glycol) has an improved circulating half-life.
Nojima Y; Suzuki Y; Yoshida K; Abe F; Shiga T; Takeuchi T; Sugiyama A; Shimizu H; Sato A
Pharm Res; 2009 Sep; 26(9):2125-32. PubMed ID: 19554429
[TBL] [Abstract][Full Text] [Related]
14. Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma.
Jonasch E; Stadler WM; Bukowski RM; Hayes TG; Varadhachary A; Malik R; Figlin RA; Srinivas S
Cancer; 2008 Jul; 113(1):72-7. PubMed ID: 18484647
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial of oral talactoferrin alfa in refractory solid tumors.
Hayes TG; Falchook GF; Varadhachary GR; Smith DP; Davis LD; Dhingra HM; Hayes BP; Varadhachary A
Invest New Drugs; 2006 May; 24(3):233-40. PubMed ID: 16193240
[TBL] [Abstract][Full Text] [Related]
16. Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumors.
Hayes TG; Falchook GS; Varadhachary A
Invest New Drugs; 2010 Apr; 28(2):156-62. PubMed ID: 19238327
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind, placebo-controlled phase II study of single-agent oral talactoferrin in patients with locally advanced or metastatic non-small-cell lung cancer that progressed after chemotherapy.
Parikh PM; Vaid A; Advani SH; Digumarti R; Madhavan J; Nag S; Bapna A; Sekhon JS; Patil S; Ismail PM; Wang Y; Varadhachary A; Zhu J; Malik R
J Clin Oncol; 2011 Nov; 29(31):4129-36. PubMed ID: 21969509
[TBL] [Abstract][Full Text] [Related]
18. Pazopanib for the treatment of metastatic renal cell carcinoma.
Pick AM; Nystrom KK
Clin Ther; 2012 Mar; 34(3):511-20. PubMed ID: 22341567
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
